Drug Control Lab functional at Bengaluru airport

Pharma/BioPharma |  News | 0 Comment | 13 May, 2019

The Kempegowda International Airport, Bengaluru (BLR Airport) – operated by Bangalore International Airport Ltd. (BIAL) now has a fully functional Drug Control Lab. “We are the...Read more

Lupin launches Clobazam tablets

Pharma/BioPharma |  News | 0 Comment | 10 May, 2019

Pharma major Lupin Limited (Lupin) announced the launch of Clobazam Tablets, 10 mg and 20 mg, having received an approval from the United States Food and Drug Administration (FDA) earlier.&...Read more

Glenmark announces results from a Phase 3 Study of Ryaltris™

Pharma/BioPharma |  News | 0 Comment | 09 May, 2019

Glenmark Pharmaceuticals has announced positive results from a Phase 3 study of Ryaltris, an investigational fixed-dose combination nasal spray for the treatment of seasonal allergic rhinit...Read more

Lupin receives tentative USFDA approval for Fosaprepitant for Injection

Pharma/BioPharma |  News | 0 Comment | 08 May, 2019

Lupin Limited (Lupin) has received tentative approval for its Fosaprepitant for Injection, 150 mg Single-Dose Vial, from the United States Food and Drug Administration (FDA) to market a gen...Read more

Alembic gets USFDA nod for Olopatadine Hydrochloride Ophthalmic Solution

Pharma/BioPharma |  News | 0 Comment | 08 May, 2019

Alembic Pharmaceuticals Limited recently announced that the Company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) ...Read more

USFDA classifies Strides Puducherry facility as Official Action Initiated (OAI)

Pharma/BioPharma |  News | 0 Comment | 06 May, 2019

Strides Pharma Science ltd. has received a communication from the US Food and Drug Administration (USFDA) on May 4, 2019, classifying the facility as OAI based on the inspection c...Read more

Glenmark announces co-promotion agreement with Otonomy

Pharma/BioPharma |  News | 0 Comment | 03 May, 2019

Glenmark Therapeutics has announced a co-promotion agreement with Otonomy, a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. Glenmark The...Read more

AstraZeneca starts AI collaboration to accelerate drug discovery

Pharma/BioPharma |  News | 0 Comment | 01 May, 2019

AstraZeneca and BenevolentAI have begun a long-term collaboration to use artificial intelligence (AI) and machine learning for the discovery and development of new treatments for chronic ki...Read more

Glenmark launches novel anti-diabetes drug in India

Pharma/BioPharma |  News | 0 Comment | 30 Apr, 2019

Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, has announced the launch of its novel, patent protected and globally-researched sodium glu...Read more

Regeneron, Sanofi’s Praluent set to reduce heart problems

Pharma/BioPharma |  News | 0 Comment | 29 Apr, 2019

Regeneron Pharmaceuticals, Inc. and Sanofi have announced that the U.S. Food and Drug Administration (FDA) has approved Praluent® (alirocumab) to reduce the ris...Read more

GVK's Mumbai International Airport awarded CEIV Pharma certification

Pharma/BioPharma |  News | 0 Comment | 25 Apr, 2019

The GVK led Mumbai International Airport Limited (MIAL) becomes the first airport in India and third in Asia to achieve IATA CEIV certification. The certificate is an industry recognit...Read more

Alembic’s Bimatoprost gets USFDA approval

Pharma/BioPharma |  News | 0 Comment | 23 Apr, 2019

Alembic Pharmaceuticals Limited recently announced that the company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) ...Read more

TB Alliance, Mylan to commercialize pretomanid to treat TB

Pharma/BioPharma |  News | 0 Comment | 23 Apr, 2019

Non-profit drug developer, TB Alliance, and pharmaceutical company, Mylan N.V. have announced a global collaboration to make the experimental drug pretomanid accessible for use in two inves...Read more

Lupin gets FDA nod for Fluoxetine Tablets USP

Pharma/BioPharma |  News | 0 Comment | 22 Apr, 2019

Pharma major Lupin Limited (Lupin) announced that it has received approval for its Fluoxetine Tablets USP, 10 mg and 20 mg, from the United States Food and Drug Administration (FDA) to mark...Read more

India to be one of the world’s ‘fastest growing bio’ hubs in 2019: CPhI data

Pharma/BioPharma |  News | 0 Comment | 18 Apr, 2019

New data from CPhI shows that, despite ongoing reputational challenges, India’s biologics market is set for robust growth in 2019 driven by biosimilars production. The India spe...Read more

Merck launches drug compound to treat and prevent Folate deficiencies

Pharma/BioPharma |  News | 0 Comment | 18 Apr, 2019

Merck has launched a new and improved proprietary product: Arcofolin™ L-Methylfolate, a monosodium salt of L-5-methyltetrahydrofolic acid for nutritional and pharmaceutical appli...Read more

Zydus Cadila announces phase III trial of Desidustat

Pharma/BioPharma |  News | 0 Comment | 17 Apr, 2019

Zydus Cadila, an innovation-driven, global pharmaceutical company, announced the Phase III trials of Desidustat, an Investigational New Drug targeted at treating anemia in non-dialysis depe...Read more

Suven receives court approval to buy assets of Rising Pharmaceuticals

Pharma/BioPharma |  News | 0 Comment | 15 Apr, 2019

Suven Life Sciences Limited, a biopharmaceutical company provider of Contract Research and Manufacturing Services (CRAMS) for global life science companies, has received the US Bankruptcy C...Read more